Profil bibliographique

Noëlly Madeleine

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées

125Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Phagocytosis and Immune RegulationPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersCancer, Lipids, and MetabolismPlant Molecular Biology Research

Publications récentes

Accès ouvert 2025 articleOpenAlex

Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial

Sonja Loges, Michael Heuser, Jörg Chromik, Grerk Sutamtewagul et autres

16 citationsNature Communications

2023 conference-abstractOpenAlex

AML Treatment By the AXL Inhibitor Bemcentinib in Combination with Cytarabine Shows Clinical Efficacy Related to TNFα and Cytotoxic Immune Cells: A Single-Cell Translational Study from the BGBC003 Trial

Niklas Beumer, Jonas Waizenegger, Michael Heuser, Jörg Chromik et autres

2 citationsBlood

Accès ouvert 2023 conference-paperOpenAlex

598 Bemcentinib + pembrolizumab show promising efficacy in metastatic NSCLC harbouring mutations associated with poor prognosis: exploratory sub-analysis from the BGBC008 trial (NCT03184571)

Gro Gausdal, David Micklem, Magnus Blø, Austin Rayford et autres

0 citationsRegular and Young Investigator Award Abstracts

2023 conference-abstractOpenAlex

Abstract 3245: AXL as a therapeutic target in STK11 mutant NSCLC

Magnus Blø, Austin Rayford, Noëlly Madeleine, Fabian Gärtner et autres

0 citationsCancer Research

Accès ouvert 2022 articleOpenAlex

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Xiao‐Zheng Liu, Anastasiia Rulina, Man Hung Choi, Line Pedersen et autres

52 citationsNature Communications

Accès ouvert 2022 articleOpenAlex

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Anastasiia Rulina, Man Hung Choi, Line Pedersen, Johanna Lepland et autres

3 citationsRePEc: Research Papers in Economics

Accès ouvert 2021 articleOpenAlex

OA01.07 A Phase II Study of the Oral Selective AXL Inhibitor Bemcentinib with Pembrolizumab in Patients with Advanced NSCLC

Matthew Krebs, Åslaug Helland, E. Arriola Aperribay, M. Dómine Gómez et autres

7 citationsJournal of Thoracic Oncology

Accès ouvert 2020 conference-abstractOpenAlex

362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis

James Spicer, Åslaug Helland, Enric Carcereny, Edurne Arriola et autres

4 citationsRegular and Young Investigator Award Abstracts

Accès ouvert 2020 articleOpenAlex

AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer

Agnete S. T. Engelsen, Katarzyna Wnuk-Lipińska, Sébastien Bougnaud, Fanny A. Pelissier Vatter et autres

33 citationsiScience

Accès ouvert 2020 articleOpenAlex

The Arabidopsis (ASHH2) CW domain binds monomethylated K4 of the histone H3 tail through conformational selection

Olena Dobrovolska, Maxim S. Bril’kov, Noëlly Madeleine, Øyvind Ødegård‐Fougner et autres

8 citationsFEBS Journal

2018 datasetOpenAlex

Solution structure of the ASHH2 CW domain with the N-terminal histone H3 tail mimicking peptide monomethylated on lysine 4

Olena Dobrovolska, Noëlly Madeleine, Øyvind Halskau

0 citationsWorldwide Protein Data Bank

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.